CIP, Cancer Immunology Project

💠A New Paper by CIP Members

💠Adverse events associated with immune checkpoint inhibitors in patients with breast cancer: A systematic review and meta-analysis

📌The frequencies of all adverse events were higher in the intervention group.

📌The most observed differences between the two groups were immune-related AEs.

📌Rash and infusion reaction were the two most frequent immune-related AEs.

📌Hyper/hypothyroidism and adrenal insufficiency had the most differences among groups.

🌐https://doi.org/10.1016/j.intimp.2021.107796

@cip_usern
@usern_net

www.tgoop.com/CIP_USERN/354

288 viewsMay 25, 2021 at 09:59

💠A New Paper by CIP Members

💠Adverse events associated with immune checkpoint inhibitors in patients with breast cancer: A systematic review and meta-analysis

📌The frequencies of all adverse events were higher in the intervention group.

📌The most observed differences between the two groups were immune-related AEs.

📌Rash and infusion reaction were the two most frequent immune-related AEs.

📌Hyper/hypothyroidism and adrenal insufficiency had the most differences among groups.

🌐https://doi.org/10.1016/j.intimp.2021.107796

@cip_usern
@usern_net

BY CIP, Cancer Immunology Project